Want to join the conversation?
$SYK 2Q15 Call: Sales growth was 2.9% in second quarter, including a negative 4.7% impact from FX translation. The sales growth was 7.6%, which includes organic growth of 6.9%. EPS on a GAAP basis for second quarter were $1.03 per share compared to $0.33 per share in 2Q14, while adjusted EPS were $1.20 per share compared to $1.08 per share in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?